Incidence density of hyperuricemia and association between metabolism-related predisposing risk factors and serum urate in Chinese adults: a cohort study

Incidence density of hyperuricemia and association between metabolism-related predisposing risk factors and serum urate in Chinese adults: a cohort study

BackgroundEvidence regarding the association between metabolism-related indicators and serum urate (SU) is limited. We aimed to obtain the incidence density of hyperuricemia and to explore the association between metabolism-related predisposing risk factors and SU.MethodsA total of 48,979 Chinese ad...

Full description

Bibliographic Details
Main Authors:	Hailun Liang, Jijuan Zhang, Hancheng Yu, Lijie Ding, Feng Liu, Jun Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Endocrinology
Subjects:	incidence density hyperuricemia serum urate metabolism-related risk factor cohort study
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1253470/full

Similar Items

Two cases of acute urate nephropathy in women with asymptomatic hyperuricemia
by: L. N. Yeliseyeva, et al.
Published: (2021-03-01)

Gender-Specific Inverse Associations Between Beans Intake, Serum Urate Levels, and Hyperuricemia: A Cross-Sectional Analysis Based on the Henan Rural Cohort Study
by: Ningning Cui, et al.
Published: (2021-01-01)

Research progress on related factors of pathogenicity of urate crystals in patients with asymptomatic hyperuricemia
by: Zhong Yang, Wang Lijuan, Wang Yuanli, Li Yasong
Published: (2022-02-01)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
by: Rebekah Wrigley, et al.
Published: (2020-03-01)

Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan
by: Masafumi Kurajoh, et al.
Published: (2024-01-01)

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
by: Pang L, et al.
Published: (2023-09-01)

Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia
by: Mo Chen, et al.
Published: (2020-07-01)

The Association between Serum Testosterone and Hyperuricemia in Males
by: Meng-Ko Tsai, et al.
Published: (2022-05-01)

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
by: Aleš Kvasnička, et al.
Published: (2023-12-01)

Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis
by: Philip C. Robinson, et al.
Published: (2021-08-01)

Hyperuricemia research progress in model construction and traditional Chinese medicine interventions
by: Hongyan Zhou, et al.
Published: (2024-03-01)

Uricase-Deficient Larval Zebrafish with Elevated Urate Levels Demonstrate Suppressed Acute Inflammatory Response to Monosodium Urate Crystals and Prolonged Crystal Persistence
by: Tanja Linnerz, et al.
Published: (2022-11-01)

Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials
by: Toshinari Takahashi, et al.
Published: (2021-11-01)

Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment
by: Rui Zhao, et al.
Published: (2022-12-01)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
by: Zijing Ran, et al.
Published: (2021-09-01)

Konjac glucomannan improves hyperuricemia through regulating xanthine oxidase, adenosine deaminase and urate transporters in rats
by: Yuan Zhang, et al.
Published: (2018-09-01)

Modulation of Urate Transport by Drugs
by: Péter Tátrai, et al.
Published: (2021-06-01)

Hyperuricemia and Hypertension: Links and Risks
by: Stewart DJ, et al.
Published: (2019-12-01)

Hyperuricemia exacerbates abdominal aortic aneurysm formation through the URAT1/ERK/MMP-9 signaling pathway
by: Jen-Chun Wang, et al.
Published: (2023-01-01)

Pu-erh ripened tea resists to hyperuricemia through xanthine oxidase and renal urate transporters in hyperuricemic mice
by: Ran Zhao, et al.
Published: (2017-02-01)

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
by: Blanka Stiburkova, et al.
Published: (2019-03-01)

A Randomized Pilot Study of DASH Patterned Groceries on Serum Urate in Individuals with Gout
by: Stephen P. Juraschek, et al.
Published: (2021-02-01)

Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors
by: Xianxin Hou, et al.
Published: (2023-11-01)

Functional Characterization of Rare Variants in OAT1/<i>SLC22A6</i> and OAT3/<i>SLC22A8</i> Urate Transporters Identified in a Gout and Hyperuricemia Cohort
by: Jiří Vávra, et al.
Published: (2022-03-01)

Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
by: Mengying Sun, et al.
Published: (2018-05-01)

Effect of Clinical Typing on Serum Urate Targets of Benzbromarone in Chinese Gout Patients: A Prospective Cohort Study
by: Xiaomei Xue, et al.
Published: (2022-01-01)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
by: Elisa Russo, et al.
Published: (2021-02-01)

Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)
by: Atsushi Tanaka, et al.
Published: (2023-07-01)

Randomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol
by: Sun F, et al.
Published: (2023-12-01)

Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study
by: Lhanoo Gunawardhana, et al.
Published: (2017-11-01)

New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds
by: Bendong Yang, et al.
Published: (2022-11-01)

Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis
by: Lin Zhang, et al.
Published: (2022-01-01)

A Novel Multi-Epitope Vaccine Based on Urate Transporter 1 Alleviates Streptozotocin-Induced Diabetes by Producing Anti-URAT1 Antibody and an Immunomodulatory Effect in C57BL/6J Mice
by: Yanjie Ma, et al.
Published: (2017-10-01)

Polydatin alleviates hyperuricemia combined with gouty arthritis in mice via regulating urate transporters, NLRP3 inflammasome and NF-κB pathway
by: Wenjing Xu, et al.
Published: (2023-06-01)

Disorder of purine metabolism in the etiopathogenesis of urate nephrolithiasis
by: S. I. Vorotyntsev, et al.
Published: (2023-04-01)

Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine Oxidase, Adenosine Deaminase and Urate Transporters in Rats
by: Yanzuo Le, et al.
Published: (2020-12-01)

A System for Discovering Novel Uricosurics Targeting Urate Transporter 1 Based on In Vitro and In Vivo Modeling
by: Xuechen Li, et al.
Published: (2024-01-01)

Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1
by: Dool-Ri Oh, et al.
Published: (2019-01-01)

Why Does Hyperuricemia Not Necessarily Induce Gout?
by: Wei-Zheng Zhang
Published: (2021-02-01)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
by: Fernando Pérez-Ruiz, et al.
Published: (2019-05-01)